Gastrointestinal stromal tumor of the rectum treated with neoadjuvant Imatinib followed by transanal endoscopic microsurgery
Open Access
- 1 January 2015
- journal article
- letter
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 28 (1) , 87-89
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Comment to “Liver Match: A prospective observational cohort study on liver transplantation in Italy”Digestive and Liver Disease, 2011
- Transanal endoscopic microsurgery after neoadjuvant therapy for rectal GISTDigestive and Liver Disease, 2011
- The Role of Neoadjuvant Imatinib Mesylate Therapy in Sphincter-Preserving Procedures for Anorectal Gastrointestinal Stromal TumorAmerican Journal of Clinical Oncology, 2011
- The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumourColorectal Disease, 2010
- Transanal endoscopic microsurgery (TEM): a minimally invasive procedure for treatment of selected rectal neoplasmsABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 2010
- Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)European Journal of Surgical Oncology, 2009
- Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndromeEuropean Journal of Gastroenterology & Hepatology, 2007
- First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy: Figure 1Gut, 2006
- Neoadjuvant Imatinib in Gastrointestinal Stromal Tumor of the Rectum: Report of a CaseDiseases of the Colon & Rectum, 2005
- Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMOAnnals of Oncology, 2005